Chiang J. Li
Oprichter bij Boston Biomedical, Inc.
Profiel
Chiang J.
Li is the founder of Cyclis Pharmaceuticals, Inc. (founded in 2001) and held the title of Vice President-Research.
Dr. Li is also the founder of Boston Biomedical, Inc. Dr. Li's current job(s) include being a Director at Cequent Pharmaceuticals, Inc. and a Faculty Member at Harvard University.
Dr. Li's former job(s) include being an Independent Director at Adhera Therapeutics, Inc. (2010-2011), an Executive Officer at Sumitomo Pharma Co., Ltd., the Chief Scientific Officer & Executive VP at ArQule, Inc. (2003-2007), and a Faculty Member at Beth Israel Deaconess Medical Center, Inc. Dr. Li's education includes a doctorate degree from Harvard University and undergraduate and graduate degrees from Harvard Mit Health Sciences & Technology.
Actieve functies van Chiang J. Li
| Bedrijven | Functie | Begin |
|---|---|---|
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Directeur/Bestuurslid | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Oprichter | - |
Eerdere bekende functies van Chiang J. Li
| Bedrijven | Functie | Einde |
|---|---|---|
| ADHERA THERAPEUTICS, INC. | Directeur/Bestuurslid | 18-07-2011 |
| ARQULE, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2007 |
| SUMITOMO PHARMA CO., LTD. | Corporate Officer/Principal | - |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Directeur/Bestuurslid | - |
Cyclis Pharmaceuticals, Inc.
 Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyclis Pharmaceuticals, Inc. researches and develops small molecule drugs for the treatment of cancer. It is engaged in the discovery and development of novel drugs which are based on the restoration and activation of cellular checkpoints. The company is headquartered in Norwood, MA. | Oprichter | - |
Opleiding van Chiang J. Li
| Harvard University | Doctorate Degree |
| Harvard Mit Health Sciences & Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ADHERA THERAPEUTICS, INC. | Health Technology |
| SUMITOMO PHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Cyclis Pharmaceuticals, Inc.
Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyclis Pharmaceuticals, Inc. researches and develops small molecule drugs for the treatment of cancer. It is engaged in the discovery and development of novel drugs which are based on the restoration and activation of cellular checkpoints. The company is headquartered in Norwood, MA. | Health Technology |
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Commercial Services |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
